{"id":1919,"date":"2025-11-10T08:45:00","date_gmt":"2025-11-10T08:45:00","guid":{"rendered":"https:\/\/www.innothyrogen.eu\/uncategorized-hr\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/"},"modified":"2025-12-07T20:57:18","modified_gmt":"2025-12-07T20:57:18","slug":"innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu","status":"publish","type":"post","link":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/","title":{"rendered":"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu"},"content":{"rendered":"\n

Uvod u InnoThyroGen na ESPT2025<\/strong><\/h2>\n\n

Od 5. do 8. studenog 2025.<\/strong> grad Rotterdam<\/strong> bio je doma\u0107in 8. me\u0111unarodnog kongresa Europskog dru\u0161tva za farmakogenomiku i personaliziranu terapiju (ESPT2025)<\/strong>.Kongres je okupio vi\u0161e od 480 stru\u010dnjaka<\/strong>, uklju\u010duju\u0107i znanstvenike, zdravstvene djelatnike, farmaceute, klini\u010dare, studente, regulatore i predstavnike industrije.Tijekom ovog va\u017enog znanstvenog doga\u0111aja, dr. Branka Zuki\u0107<\/a><\/strong> iz IMGGE<\/a> predstavljala je projekt InnoThyroGen<\/strong> i pridonijela pove\u0107anju njegove vidljivosti unutar europske farmakogenomske zajednice.<\/p>\n\n

O doga\u0111aju: InnoThyroGen na ESPT2025<\/strong><\/h2>\n\n

ESPT2025 se fokusirao na trenutna dostignu\u0107a i budu\u0107e smjerove u farmakogenomici i personaliziranoj medicini.Program je pokrivao \u0161irok raspon tema, uklju\u010duju\u0107i klini\u010dku primjenu, psihijatriju, onkologiju, kardiologiju, dijabetes, pedijatriju, transplantaciju, regulatorne izazove, teku\u0107u biopsiju i alate za podr\u0161ku odlu\u010divanju.Osim toga, kongres je istaknuo inovacije u tehnologijama genotipizacije i nacionalne inicijative koje podr\u017eavaju personaliziranu terapiju.<\/p>\n\n

Zbog svoje multidisciplinarne strukture, doga\u0111aj je stvorio idealno okru\u017eenje za suradnju izme\u0111u osnovnih, klini\u010dkih i translacijskih istra\u017eiva\u010da. Nadalje, pomogao je povezivanju znanstvenika s regulatorima i dionicima iz industrije. <\/p>\n\n

IMGGE predstavlja InnoThyroGen na ESPT2025<\/strong><\/h2>\n\n

Tijekom kongresa, dr. Branka Zuki\u0107<\/strong> predstavila je poster pod naslovom:\u201ePopulacijska farmakogenomika za klini\u010dku primjenu u Srbiji: Uvidi iz studije PharmGenHUB.\u201d<\/strong><\/p>\n\n

Njezina prezentacija ponudila je vrijedne uvide u farmakogenomiku na razini populacije i njezinu potencijalnu primjenu u klini\u010dkoj praksi.Nadalje, iskoristila je priliku da sudionicima predstavi ciljeve, aktivnosti i znanstveni smjer<\/strong> projekta InnoThyroGen<\/strong>.Kao rezultat toga, projekt je dosegao vrlo relevantnu publiku stru\u010dnjaka koji rade u podru\u010djima usko povezanima s personaliziranom medicinom i genomskim istra\u017eivanjem.<\/p>\n\n

Utjecaj InnoThyroGen na ESPT2025<\/strong><\/h2>\n\n

Doga\u0111aj je donio nekoliko va\u017enih rezultata za projekt:<\/p>\n\n

    \n
  • Vi\u0161e od 480 me\u0111unarodnih sudionika<\/strong> saznalo je za InnoThyroGen.<\/li>\n\n\n\n
  • Izravne rasprave pove\u0107ale su svijest o ciljevima i budu\u0107im aktivnostima projekta.<\/li>\n\n\n\n
  • Dionici su stekli jasnije razumijevanje doprinosa projekta personaliziranoj medicini.<\/li>\n\n\n\n
  • Umre\u017eavanje je oja\u010dalo veze izme\u0111u InnoThyroGen i vode\u0107ih europskih istra\u017eiva\u010da u farmakogenomici.<\/li>\n\n\n\n
  • Kongres je podr\u017eao \u0161iru diseminaciju InnoThyroGen unutar znanstvenih, klini\u010dkih i regulatornih zajednica.<\/li>\n<\/ul>\n\n

    Kao posljedica toga, InnoThyroGen na ESPT2025<\/strong> zna\u010dajno je pobolj\u0161ao vidljivost projekta i oja\u010dao njegovu relevantnost u europskom ekosustavu personalizirane medicine.<\/p>\n\n

    Zaklju\u010dak<\/strong><\/h2>\n\n

    ESPT2025 se pokazao kao vrijedna platforma za znanstvenu razmjenu i suradnju.Kroz aktivno sudjelovanje, dr. Zuki\u0107 pro\u0161irila je svijest o projektu i otvorila nove mogu\u0107nosti za dijalog unutar klini\u010dkog, akademskog i regulatornog sektora.Na taj na\u010din, InnoThyroGen na ESPT2025<\/strong> podr\u017eava kontinuirani napredak u personaliziranoj terapiji i ja\u010da ulogu projekta unutar europskog farmakogenomskog krajolika.<\/p>\n\n

    Ostanite u tijeku<\/strong><\/h2>\n\n

    Pratite nas za vi\u0161e a\u017euriranja s nadolaze\u0107ih znanstvenih doga\u0111aja.Pratite InnoThyroGen<\/strong> na LinkedInu, X (Twitteru), Facebooku i Instagramu<\/strong> za najnovije vijesti, aktivnosti i istra\u017eiva\u010dke uvide.<\/p>\n\n

    \n
    \"\"<\/figure>\n\n\n\n
    \"\"<\/figure>\n\n\n\n
    \"\"<\/figure>\n<\/figure>\n","protected":false},"excerpt":{"rendered":"

    Uvod u InnoThyroGen na ESPT2025 Od 5. do 8. studenog 2025. grad Rotterdam bio je doma\u0107in 8. me\u0111unarodnog kongresa Europskog dru\u0161tva za farmakogenomiku i personaliziranu terapiju (ESPT2025).Kongres je okupio vi\u0161e od 480 stru\u010dnjaka, uklju\u010duju\u0107i znanstvenike, zdravstvene djelatnike, farmaceute, klini\u010dare, studente, regulatore i predstavnike industrije.Tijekom ovog va\u017enog znanstvenog doga\u0111aja, dr. Branka Zuki\u0107 iz IMGGE predstavljala je […]<\/p>\n","protected":false},"author":1,"featured_media":1920,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[43,41,42,45,60,44],"class_list":["post-1919","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti","tag-eufunded","tag-horizoneurope","tag-innothyrogen","tag-personalisedmedicine","tag-pharmacogenomics","tag-thyroidhealth"],"yoast_head":"\nInnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu<\/title>\n<meta name=\"description\" content=\"InnoThyroGen na ESPT2025: Dr. Branka Zuki\u0107 predstavila je istra\u017eivanje u Rotterdamu, ja\u010daju\u0107i suradnju i pove\u0107avaju\u0107i vidljivost projekta me\u0111u vode\u0107im stru\u010dnjacima u farmakogenomici i personaliziranoj terapiji.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu\" \/>\n<meta property=\"og:description\" content=\"InnoThyroGen na ESPT2025: Dr. Branka Zuki\u0107 predstavila je istra\u017eivanje u Rotterdamu, ja\u010daju\u0107i suradnju i pove\u0107avaju\u0107i vidljivost projekta me\u0111u vode\u0107im stru\u010dnjacima u farmakogenomici i personaliziranoj terapiji.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/\" \/>\n<meta property=\"og:site_name\" content=\"InnoThyroGen EU projekt\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61571994011521\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-10T08:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-07T20:57:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/ESPT-2025.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1114\" \/>\n\t<meta property=\"og:image:height\" content=\"752\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@innothyrogenEU\" \/>\n<meta name=\"twitter:site\" content=\"@innothyrogenEU\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/person\\\/f6b134e97e8e2d2e2289a7953108188b\"},\"headline\":\"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu\",\"datePublished\":\"2025-11-10T08:45:00+00:00\",\"dateModified\":\"2025-12-07T20:57:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/\"},\"wordCount\":465,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/ESPT-2025.jpg\",\"keywords\":[\"#EUfunded\",\"#HorizonEurope\",\"#InnoThyroGen\",\"#Personalisedmedicine\",\"#Pharmacogenomics\",\"#ThyroidHealth\"],\"articleSection\":[\"Vijesti\"],\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/\",\"name\":\"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/ESPT-2025.jpg\",\"datePublished\":\"2025-11-10T08:45:00+00:00\",\"dateModified\":\"2025-12-07T20:57:18+00:00\",\"description\":\"InnoThyroGen na ESPT2025: Dr. Branka Zuki\u0107 predstavila je istra\u017eivanje u Rotterdamu, ja\u010daju\u0107i suradnju i pove\u0107avaju\u0107i vidljivost projekta me\u0111u vode\u0107im stru\u010dnjacima u farmakogenomici i personaliziranoj terapiji.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/ESPT-2025.jpg\",\"contentUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/ESPT-2025.jpg\",\"width\":1114,\"height\":752},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/vijesti\\\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Po\u010detna\",\"item\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#website\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\",\"name\":\"InnoThyroGen EU Project\",\"description\":\"Inovacije u zdravlju \u0161titnja\u010de s genomikom i prediktivnim algoritmima kroz suradni\u010dku izvrsnost\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hr\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#organization\",\"name\":\"InnoThyroGen EU projekt\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_EMAIL_without_bacground_vertical.png\",\"contentUrl\":\"https:\\\/\\\/www.innothyrogen.eu\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_EMAIL_without_bacground_vertical.png\",\"width\":534,\"height\":520,\"caption\":\"InnoThyroGen EU projekt\"},\"image\":{\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61571994011521\",\"https:\\\/\\\/x.com\\\/innothyrogenEU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/innothyrogen-eu-project\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/#\\\/schema\\\/person\\\/f6b134e97e8e2d2e2289a7953108188b\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hr\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/www.innothyrogen.eu\"],\"url\":\"https:\\\/\\\/www.innothyrogen.eu\\\/hr\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu","description":"InnoThyroGen na ESPT2025: Dr. Branka Zuki\u0107 predstavila je istra\u017eivanje u Rotterdamu, ja\u010daju\u0107i suradnju i pove\u0107avaju\u0107i vidljivost projekta me\u0111u vode\u0107im stru\u010dnjacima u farmakogenomici i personaliziranoj terapiji.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/","og_locale":"hr_HR","og_type":"article","og_title":"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu","og_description":"InnoThyroGen na ESPT2025: Dr. Branka Zuki\u0107 predstavila je istra\u017eivanje u Rotterdamu, ja\u010daju\u0107i suradnju i pove\u0107avaju\u0107i vidljivost projekta me\u0111u vode\u0107im stru\u010dnjacima u farmakogenomici i personaliziranoj terapiji.","og_url":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/","og_site_name":"InnoThyroGen EU projekt","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61571994011521","article_published_time":"2025-11-10T08:45:00+00:00","article_modified_time":"2025-12-07T20:57:18+00:00","og_image":[{"width":1114,"height":752,"url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/ESPT-2025.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_creator":"@innothyrogenEU","twitter_site":"@innothyrogenEU","twitter_misc":{"Napisao\/la":"admin","Procijenjeno vrijeme \u010ditanja":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/#article","isPartOf":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/"},"author":{"name":"admin","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/person\/f6b134e97e8e2d2e2289a7953108188b"},"headline":"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu","datePublished":"2025-11-10T08:45:00+00:00","dateModified":"2025-12-07T20:57:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/"},"wordCount":465,"commentCount":0,"publisher":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/ESPT-2025.jpg","keywords":["#EUfunded","#HorizonEurope","#InnoThyroGen","#Personalisedmedicine","#Pharmacogenomics","#ThyroidHealth"],"articleSection":["Vijesti"],"inLanguage":"hr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/","url":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/","name":"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu","isPartOf":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/#primaryimage"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/#primaryimage"},"thumbnailUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/ESPT-2025.jpg","datePublished":"2025-11-10T08:45:00+00:00","dateModified":"2025-12-07T20:57:18+00:00","description":"InnoThyroGen na ESPT2025: Dr. Branka Zuki\u0107 predstavila je istra\u017eivanje u Rotterdamu, ja\u010daju\u0107i suradnju i pove\u0107avaju\u0107i vidljivost projekta me\u0111u vode\u0107im stru\u010dnjacima u farmakogenomici i personaliziranoj terapiji.","breadcrumb":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/"]}]},{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/#primaryimage","url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/ESPT-2025.jpg","contentUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/12\/ESPT-2025.jpg","width":1114,"height":752},{"@type":"BreadcrumbList","@id":"https:\/\/www.innothyrogen.eu\/hr\/vijesti\/innothyrogen-na-espt2025-napredak-farmakogenomike-u-rotterdamu\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Po\u010detna","item":"https:\/\/www.innothyrogen.eu\/hr\/"},{"@type":"ListItem","position":2,"name":"InnoThyroGen na ESPT2025: Napredak farmakogenomike u Rotterdamu"}]},{"@type":"WebSite","@id":"https:\/\/www.innothyrogen.eu\/hr\/#website","url":"https:\/\/www.innothyrogen.eu\/hr\/","name":"InnoThyroGen EU Project","description":"Inovacije u zdravlju \u0161titnja\u010de s genomikom i prediktivnim algoritmima kroz suradni\u010dku izvrsnost","publisher":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.innothyrogen.eu\/hr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hr"},{"@type":"Organization","@id":"https:\/\/www.innothyrogen.eu\/hr\/#organization","name":"InnoThyroGen EU projekt","url":"https:\/\/www.innothyrogen.eu\/hr\/","logo":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/logo\/image\/","url":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/03\/logo_EMAIL_without_bacground_vertical.png","contentUrl":"https:\/\/www.innothyrogen.eu\/wp-content\/uploads\/2025\/03\/logo_EMAIL_without_bacground_vertical.png","width":534,"height":520,"caption":"InnoThyroGen EU projekt"},"image":{"@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61571994011521","https:\/\/x.com\/innothyrogenEU","https:\/\/www.linkedin.com\/company\/innothyrogen-eu-project\/"]},{"@type":"Person","@id":"https:\/\/www.innothyrogen.eu\/hr\/#\/schema\/person\/f6b134e97e8e2d2e2289a7953108188b","name":"admin","image":{"@type":"ImageObject","inLanguage":"hr","@id":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7ddcd85f5d67b5a8ee8daedcc5e9afa1fef935b44ea366e04fb0f0185cea3977?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/www.innothyrogen.eu"],"url":"https:\/\/www.innothyrogen.eu\/hr\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/comments?post=1919"}],"version-history":[{"count":1,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1919\/revisions"}],"predecessor-version":[{"id":1923,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/posts\/1919\/revisions\/1923"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/media\/1920"}],"wp:attachment":[{"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/media?parent=1919"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/categories?post=1919"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.innothyrogen.eu\/hr\/wp-json\/wp\/v2\/tags?post=1919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}